Bacteriophage-resistant mutants in yersinia pestis: Identification of phage receptors and attenuation for mice

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Filippov, Andrey A ^a   Sergueev, Kirill V ^a   He, Yunxiu ^a   Huang, Xiao Zhe ^a   Gnade, Bryan T ^a   Mueller, Allen J ^a   Fernandez Prada, Carmen M ^a   Nikolich, Mikeljon P ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGE RECEPTOR; LIPOPOLYSACCHARIDE; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIOLYSIS; BACTERIOPHAGE; BACTERIUM MUTANT; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; GENETIC COMPLEMENTATION; GENETIC RESISTANCE; LD 50; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PLAGUE; PROTEIN LOCALIZATION; SITE DIRECTED MUTAGENESIS; WAAA GENE; YERSINIA PESTIS; YRBH GENE; ANIMAL; GENETICS; METABOLISM; MUTATION; PATHOGENICITY; PHYSIOLOGY; PROTEIN TRANSPORT; SPECIES DIFFERENCE; VIROLOGY;

MUS; YERSINIA PESTIS;

ANIMALS; BACTERIOPHAGES; FEMALE; LIPOPOLYSACCHARIDES; MICE; MUTAGENESIS, SITE-DIRECTED; MUTATION; PLAGUE; PROTEIN TRANSPORT; RECEPTORS, VIRUS; SPECIES SPECIFICITY; YERSINIA PESTIS;

EID: 80053226865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025486     Document Type: Article

References (95)

1. Perry RD, Fetherston JD, (1997) Yersinia pestis - etiologic agent of plague. Clin Microbiol Rev 10: 35-66.
2. Gage KL, Kosoy MY, (2005) Natural history of plague: perspectives from more than a century of research. Annu Rev Entomol 50: 505-528.
3. Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, et al. (2000) Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 283: 2281-2290.
4. Welch TJ, Fricke WF, McDermott PF, White DG, Rosso ML, et al. (2007) Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2 (3): e309.
5. Anisimov AP, Amoako KK, (2006) Treatment of plague: promising alternatives to antibiotics. J Med Microbiol 55: 1461-1475.
6. Housby JN, Mann NH, (2009) Phage therapy. Drug Discov Today 14: 536-540.
7. Deresinski S, (2009) Bacteriophage therapy: exploiting smaller fleas. Clin Infect Dis 48: 1096-1101.
8. Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhlia L, et al. (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11: 69-86.
9. Pokrovskaya MP, (1929) A plague bacteriophage in dead susliks. Gigiena Epidemiol 12: 31-34.
10. Advier M, (1933) Etude d'un bactériophage antipesteux. Bull Soc Pathol Exotiques 26: 94-99.
11. Burrows TW, (1962) Phage and bacteriocin investigations with Pasteurella pestis and other bacteria. Nature 193: 397-398.
12. Knapp W, (1963) Varying behavior of Pasteurella phages. Zentralbl Bakteriol 190: 39-46.
13. Hertman I, (1964) Bacteriophage common to Pasteurella pestis and Escherichia coli. J Bacteriol 88: 1002-1005.
14. Larina VS, Anisimov PI, Adamov AK, (1970) A novel strain of plague bacteriophage for identification of Pasteurella pestis. Probl Particularly Dangerous Infect 11: 132-136.
15. Arutyunov YI, (1970) Biological characteristics of plague and pseudotuberculosis bacteriophages. Zh Mikrobiol Epidemiol Immunobiol 8: 106-111.
16. Plotnikov OP, Larina VS, Kondrashin YI, Vorob'yova TV, (1982) Spectrum of lytic activity of bacteriophages isolated from soil of rodents' holes. In: Anisimov PI, Karaseva ZN, Konnov NP, editors. Selection and Genetics of Causative Agents of Particularly Dangerous Infections Saratov Institute "Microbe" Press pp. 56-61.
17. Novoseltsev NN, Marchenkov VI, (1990) Yersinia pestis phage of a new serovar. Zh Mikrobiol Epidemiol Immunobiol 11: 9-12.
18. Garcia E, Elliott JM, Ramanculov E, Chain PS, Chu MC, et al. (2003) The genome sequence of Yersinia pestis bacteriophage φA1122 reveals an intimate history with the coliphage T3 and T7 genomes. J Bacteriol 185: 5248-5262.
19. Garcia E, Chain P, Elliott JM, Bobrov AG, Motin VL, et al. (2008) Molecular characterization of L-413C, a P2-related plague diagnostic bacteriophage. Virology 372: 85-96.
20. Schwudke D, Ergin A, Michael K, Volkmar S, Appel B, et al. (2008) Broad-host-range Yersinia phage PY100: genome sequence, proteome analysis of virions, and DNA packaging strategy. J Bacteriol 190: 332-342.
21. Zhao X, Wu W, Qi Z, Cui Y, Yan Y, et al. (2010) The complete genome sequence and proteomics of Yersinia pestis phage Yep-phi. J Gen Virol 92: 216-221.
22. Chu MC, (2000) Laboratory manual of plague diagnostic tests Fort Collins Centers for Disease Control and Prevention.
23. Naumov AV, Samoilova LV, eds. (1992) Manual on prophylaxis of plague Saratov Russian Research Anti-Plague Institute "Microbe" Press.
24. Bobrov AG, Kirillina OA, Filippov AA, Kutyrev VV, (1999) Restriction mapping of DNA of plague diagnostic phages Pokrovskaya and L-413C. Probl Particularly Dangerous Infect 79: 138-144.
25. Gunnison JB, Larson A, Lazarus AS, (1951) Rapid differentiation between Pasteurella pestis and Pasteurella pseudotuberculosis by action of bacteriophage. J Infect Dis 88: 254-255.
26. Schofield DA, Molineux IJ, Westwater C, (2009) Diagnostic bioluminescent phage for detection of Yersinia pestis. J Clin Microbiol 47: 3887-3894.
27. Sergueev KV, He Y, Borschel RH, Nikolich MP, Filippov AA, (2010) Rapid and sensitive detection of Yersinia pestis using amplification of plague diagnostic bacteriophages monitored by real-time PCR. PLoS ONE 5 (6): e11337.
28. Smith HW, Huggins MB, (1983) Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 129: 2659-2675.
29. Levin BR, Bull JJ, (2004) Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol 2: 166-173.
30. Gill JJ, Hyman P, (2010) Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 11: 2-14.
31. Labrie SJ, Samson JE, Moineau S, (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8: 317-327.
32. Lindberg AA, (1973) Bacteriophage receptors. Annu Rev Microbiol 27: 205-241.
33. Heller KJ, (1992) Molecular interaction between bacteriophage and the gram-negative cell envelope. Arch Microbiol 158: 235-248.
34. Smith HW, Huggins MB, (1982) Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128: 307-318.
35. Smith HW, Huggins MB, Shaw KM, (1987) The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 133: 1111-1126.
36. Pickard D, Toribio AL, Petty NK, van Tonder A, Yu L, et al. (2010) A conserved acetyl esterase domain targets diverse bacteriophages to the Vi capsular receptor of Salmonella enterica serovar Typhi. J Bacteriol 192: 5746-5754.
37. Pruzzo C, Valisena S, Satta G, (1983) Laboratory and wild-type Klebsiella pneumoniae strains carrying mannose-inhibitable adhesins and receptors for coliphages T3 and T7 are more pathogenic for mice than are strains without such receptors. Infect Immun 39: 520-527.
38. Ricci V, Piddock LJ, (2010) Exploiting the role of TolC in pathogenicity: identification of a bacteriophage for eradication of Salmonella serovars from poultry. Appl Environ Microbiol 76: 1704-1706.
39. Begum YA, Chakraborty S, Chowdhury A, Ghosh AN, Nair GB, et al. (2010) Isolation of a bacteriophage specific for CS7-expressing strains of enterotoxigenic Escherichia coli. J Med Microbiol 59: 266-272.
40. Spears PA, Suyemoto MM, Palermo AM, Horton JR, Hamrick TS, et al. (2008) A Listeria monocytogenes mutant defective in bacteriophage attachment is attenuated in orally inoculated mice and impaired in enterocyte intracellular growth. Infect Immun 76: 4046-4054.
41. Zinder ND, (1958) Lysogenization and superinfection immunity in Salmonella. Virology 5: 291-326.
42. Wright A, (1971) Mechanism of conversion of the salmonella O antigen by bacteriophage ε34. J Bacteriol 105: 927-936.
43. Schoonejans E, Expert D, Toussaint A, (1987) Characterization and virulence properties of Erwinia chrysanthemi lipopolysaccharide-defective, φEC2-resistant mutants. J Bacteriol 169: 4011-4017.
44. Al-Hendy A, Toivanen P, Skurnik M, (1991) Expression cloning of the Yersinia enterocolitica O:3 rfb gene cluster in Escherichia coli K12. Microb Pathog 10: 47-59.
45. Zhang L, Skurnik M, (1994) Isolation of an R- M+ mutant of Yersinia enterocolitica serotype O:8 and its application in construction of rough mutants utilizing mini-Tn5 derivatives and lipopolysaccharide-specific phage. J Bacteriol 176: 1756-1760.
46. Petty NK, Foulds IJ, Pradel E, Ewbank JJ, Salmond GP, (2006) A generalized transducing phage (φIF3) for the genomically sequenced Serratia marcescens strain Db11: a tool for functional genomics of an opportunistic human pathogen. Microbiology 152: 1701-1708.
47. Petty NK, Toribio AL, Goulding D, Foulds I, Thomson N, et al. (2007) A generalized transducing phage for the murine pathogen Citrobacter rodentium. Microbiology 153: 2984-2988.
48. Goodridge LD, (2010) Designing Phage Therapeutics. Curr Pharm Biotechnol 11: 15-27.
49. Welkos S, Pitt ML, Martinez M, Friedlander A, Vogel P, et al. (2002) Determination of the virulence of the pigmentation-deficient and pigmentation/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 20: 2206-2214.
50. Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, et al. (2001) Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413: 523-527.
51. Anisimov AP, Dentovskaya SV, Kondakova AN, Lindner B, Shaikhutdinova RZ, et al. (2010) Yersinia pestis lipopolysaccharide in host-pathogen interactions. In: Shafferman A, Ordentlich A, Velan B, editors. The Challenge of Highly Pathogenic Microorganisms: Mechanisms of Virulence and Novel Medical Countermeasures London, New York Springer pp. 77-87.
52. No authors listed (1992) Centers for Disease Control and Prevention. Pneumonic plague - Arizona. JAMA 268: 2146-2147.
53. Brubaker RR, (1969) Mutation rate to nonpigmentation in Pasteurella pestis. J Bacteriol 98: 1404-1406.
54. Jawetz E, Meyer KF, (1943) Avirulent strains of Pasteurella pestis. J Infect Dis 73: 124-143.
55. Burrows TW, Bacon GW, (1960) V and W antigens in strains of Pasteurella pseudotuberculosis. Br J Exp Pathol 41: 38-44.
56. Appleyard RK, (1954) Segregation of new lysogenic types during growth of a doubly lysogenic strain derived from Escherichia coli K-12. Genetics 39: 440-452.
57. Herrero M, de Lorenzo V, Timmis KN, (1990) Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J Bacteriol 172: 6557-6567.
58. Sunshine MG, Thorn M, Gibbs W, Calendar R, Kelly B, (1971) P2 phage amber mutants: characterization by use of a polarity suppressor. Virology 46: 691-702.
59. Bertani LE, (1957) The effect of the inhibition of protein synthesis on the establishment of lysogeny. Virology 4: 53-71.
60. Kerby GP, Gowdy RA, Dillon ES, Csaky TZ, Sharp DG, et al. (1949) Purification, pH stability and sedimentation properties of the T7 bacteriophage of Escherichia coli. J Immunol 63: 93-107.
61. Knapp W, Zwillenberg LO, (1964) Morphological differences between Pasteurella bacteriophages. Arch Gesamte Virusforsch 14: 563-566.
62. Ackermann HW, Poty F, (1969) Relationship between coliphages T2 and 3, and phage PST of Pasteurella pseudotuberculosis. Rev Can Biol 28: 201-204.
63. Gurleva GG, Arutyunov YI, Khaliapina EE, (1981) Serologic relationship and specificity of action of pseudotuberculosis and coli-dysentery phages. Zh Mikrobiol Epidemiol Immunobiol 5: 65-68.
64. Kotlyarova RI, (1956) Pseudotuberculosis bacteriophage and its characteristics. Proceedings of Research Anti-Plague Institute of Caucasus and Transcaucasia Stavropol pp. 234-241.
65. Shashaev MA, (1966) Comparative characterization of plague and pseudotuberculosis phages. Production of bacterial preparations for prophylaxis and diagnostics of particularly dangerous infections Saratov pp. 350-356.
66. Sambrook J, Fritsch EF, Maniatis T, (1989) Molecular cloning: a laboratory manual, 2nd ed Cold Spring Harbor Cold Spring Harbor Laboratory Press.
67. Anderson GW, Leary SEC, Williamson ED, Titball RW, Welkos SL, et al. (1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and-negative strains of Yersinia pestis. Infect Immun 64: 4580-4585.
68. Datsenko KA, Wanner BL, (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645.
69. Oka A, Sugisaki H, Takanami M, (1981) Nucleotide sequence of the kanamycin resistance transposon Tn903. J Mol Biol 147: 217-226.
70. Mingeot-Leclercq M-P, Glupczynski Y, Tulkens PM, (1999) Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 43: 727-737.
71. Kado C, Liu S-T, (1981) Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145: 1365-1373.
72. Surgalla MJ, Beesley ED, (1969) Congo red-agar plating medium for detecting pigmentation in Pasteurella pestis. Appl Microbiol 18: 834-837.
73. Higuchi K, Smith JL, (1961) Studies on the nutrition and physiology of Pasteurella pestis. VI. A differential plating medium for the estimation of the mutation rate to avirulence. J Bacteriol 81: 605-608.
74. Tan L, Darby C, (2006) Yersinia pestis YrbH is a multifunctional protein required for both 3-deoxy-D-manno-oct-2-ulosonic acid biosynthesis and biofilm formation. Mol Microbiol 61: 861-870.
75. Batson HC, (1956) An introduction to statistics in the medical sciences Minneapolis Burgess Publishing Co.
76. Anisimov AP, Dentovskaya SV, Titareva GM, Bakhteeva IV, Shaikhutdinova RZ, et al. (2005) Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B. Infect Immun 73: 7324-7331.
77. Lebedeva SA, (2000) Yersinia pestis variants resistant to diagnostic bacteriophage and problems connected with them. Zh Mikrobiol Epidemiol Immunobiol 3: 99-104.
78. Feodorova VA, Pan'kina LN, Savostina EP, Kuznetsov OS, Konnov NP, et al. (2009) Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens. Vaccine 27: 2240-2250.
79. Qimron U, Marintcheva B, Tabor S, Richardson CC, (2006) Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage. Proc Natl Acad Sci USA 103: 19039-19044.
80. Tan L, Darby C, (2005) Yersinia pestis is viable with endotoxin composed of only lipid A. J Bacteriol 187: 6599-6600.
81. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
82. Feodorova VA, Pan'kina LN, Savostina EP, Sayapina LV, Motin VL, et al. (2007) A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine 25: 7620-7628.
83. Dunn JJ, Studier FW, (1983) Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements. J Mol Biol 166: 477-535.
84. Skurnik M, Venho R, Bengoechea JA, Moriyón I, (1999) The lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3 is required for virulence and plays a role in outer membrane integrity. Mol Microbiol 31: 1443-1462.
85. Yethon JA, Gunn JS, Ernst RK, Miller SI, Laroche L, et al. (2000) Salmonella enterica serovar Typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence in vivo. Infect Immun 68: 4485-4491.
86. Ramjeet M, Deslandes V, St Michael F, Cox AD, Kobisch M, et al. (2005) Truncation of the lipopolysaccharide outer core affects susceptibility to antimicrobial peptides and virulence of Actinobacillus pleuropneumoniae serotype 1. J Biol Chem 280: 39104-39114.
87. Loutet SA, Flannagan RS, Kooi C, Sokol PA, Valvano MA, (2006) A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 188: 2073-2080.
88. Montminy SW, Khan N, McGrath S, Walkowicz MJ, Shar F, et al. (2006) Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 7: 1066-1073.
89. Goguen JD, Yother J, Straley SC, (1984) Genetic analysis of the low calcium response in Yersinia pestis Mu d1(Ap lac) insertion mutants. J Bacteriol 160: 842-848.
90. Straley SC, Bowmer WS, (1986) Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun 51: 445-454.
91. Kutyrev VV, Filippov AA, Shavina NY, Protsenko OA, (1989) Genetic analysis and simulation of the virulence of Yersinia pestis. Mol Genet Mikrobiol Virusol 8: 42-47.
92. Jackson S, Burrows TW, (1956) The pigmentation of Pasteurella pestis on a defined medium containing haemin. Brit J Exp Pathol 37: 570-576.
93. Iteman I, Guiyoule A, de Almeida AM, Guilvout I, Baranton G, et al. (1993) Relationship between loss of pigmentation and deletion of the chromosomal iron-regulated irp2 gene in Yersinia pestis: evidence for separate but related events. Infect Immun 61: 2717-2722.
94. Bearden SW, Fetherston JD, Perry RD, (1997) Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect Immun 65: 1659-1668.
95. Tidhar A, Flashner Y, Cohen S, Levi Y, Zauberman A, et al. (2009) The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague. PLoS ONE 4 (9): e7023.